CELH
Celsius Holdings, Inc.
CELH has the edge over COST overall, supported by stronger modeled upside and stronger valuation.
COST
Costco Wholesale Corporation
COST trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
COST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Unavailable | |
| Strong |
COST's revenue, profitability and balance sheet are currently healthy. There isn't enough data to rate its cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over COST in the historical PE scenario, which offers more potential upside but is not a forecast.
COST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 37x | $764 | -30% |
| Fair | 43x | $891 | -18% |
| Expensive | 53x | $1,102 | +0.9% |
| Current | 53x | $1,092 | — |
Historical ranges are pointers, not guarantees.
COST's PE is in its expensive range at 53x.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
COST Forward outlook
There aren't enough analyst estimates for COST to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
COST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $20.76 | +14% |
| Q2 2026 | $19.88 | +13% |
| Q1 2026 | $19.23 | +12% |
| Q4 2025 | $18.67 | +9.7% |
| Q3 2025 | $18.21 | +10% |
| Q2 2025 | $17.62 | +9.2% |
| Q1 2025 | $17.12 | +12% |
| Q4 2024 | $17.02 | +16% |
COST has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the stronger quarterly revenue trend. Revenue is up 17% for CELH versus up 12% for COST.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
COST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $70.5B | +12% |
| Q1 2026 | $69.6B | +9.2% |
| Q4 2025 | $67.3B | +8.3% |
| Q3 2025 | $86.2B | +8.1% |
| Q2 2025 | $63.2B | +8% |
| Q1 2025 | $63.7B | +9% |
| Q4 2024 | $62.2B | +7.5% |
| Q3 2024 | $79.7B | +1% |
COST's revenue has grown year over year every quarter since late 2020: $70.5B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4% | 0 points |
| Q1 2026 | 3.7% | +0.1 points |
| Q4 2025 | 3.7% | +0.1 points |
| Q3 2025 | 3.9% | +0.1 points |
| Q2 2025 | 4% | +0.3 points |
| Q1 2025 | 3.6% | +0.1 points |
| Q4 2024 | 3.5% | +0.1 points |
| Q3 2024 | 3.8% | +0.3 points |
COST's operating margin was 4% last quarter, about level with the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
COST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $1.7B | +6% |
| Q4 2025 | $3.2B | +58% |
| Q1 2025 | $1.6B | +$1.9B |
| Q4 2024 | $2B | -45% |
| Q1 2024 | -$300M | -113% |
| Q4 2023 | $3.6B | +133% |
| Q2 2023 | $721M | +93% |
| Q1 2023 | $2.3B | +$2.6B |
COST generated $8.5B in free cash flow over the past year, up 41% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over COST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
COST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -3K shares |
| 1 year | -0.1% | -376K shares |
| 3 years | 0% | -25K shares |
| 5 years | 0% | +81K shares |
| Available history | +0.2% | +747K shares |
COST has 444M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $184M |
| Q1 2026 | $209M |
| Q4 2025 | $210M |
| Q1 2025 | $205M |
| Q4 2024 | $207M |
| Q1 2024 | $160M |
| Q4 2023 | $162M |
| Q2 2023 | $162M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
COST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -0.3x | Net Cash |
| Q4 2019 | -0.4x | Net Cash |
COST has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
COST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.8 | Overbought |
| Stochastic | 91.5 | Overbought |
COST's weekly RSI is 72 (overbought) and its Stochastic is 91 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over COST on valuation relative to its sector.
COST PE vs Consumer Defensive Sector
| Metric | COST | Sector median | Relative |
|---|---|---|---|
| PE | 53x | 19x | 170% above |
| PE % | 80 | 18 | 62 pts above |
COST is trading at 53x earnings, a 170% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
COST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $992.6 | 10% above |
| 20 week MA | $957.7 | 14% above |
| 50 week MA | $964.9 | 13% above |
| 100 week MA | $964.1 | 13% above |
| 200 week MA | $821.6 | 33% above |
COST has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
COST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $294.1 | $364.6 | +24% |
| 2021 | $364.6 | $550.4 | +51% |
| 2022 | $550.4 | $462.7 | -16% |
| 2023 | $462.7 | $660.1 | +43% |
| 2024 | $660.1 | $939.7 | +42% |
| 2025 | $939.7 | $873.4 | -7.1% |
| 2026 YTD | $873.4 | $1,092.2 | +25% |
COST has the edge over CELH on returns for 2026, with the stronger performance.